Kaival Brands Narrows Q1 Loss to $620,787 as Royalty Revenue Slides 42%
Kaival Brands Innovations Group, a vaping products company, reported a net loss of $620,787 for the three months ending January 31, 2026, down from a $4.1 million loss in the prior-year quarter. Royalty revenue fell to $92,938 from $159,921 a year earlier.
Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL), a vaping products company that licenses distribution rights to Phillip Morris International, reported a net loss of $620,787 for the three months ending January 31, 2026, compared to a net loss of $4.06 million in the same period a year earlier. Read more earnings reports.
Total revenue dropped 54% to $92,938 from $202,603 in the prior-year quarter. Royalty revenue, the company's primary income source, declined 42% to $92,938 from $159,921. The company reported no product sales revenue in the current quarter, down from $42,682 a year earlier.
Operating expenses fell sharply to $713,725 from $4.28 million in the prior-year period. General and administrative expenses accounted for the entire operating expense total in both periods.
The company raised $1.02 million through the issuance of 4.89 million common shares during the quarter. Cash increased to $797,500 as of January 31, 2026, up from $534,406 at October 31, 2025. The company canceled 2.95 million common shares during the period.
Total assets stood at $931,430 at quarter-end, up from $669,256 three months earlier. Current liabilities declined to $434,362 from $569,289, driven by a $125,000 reduction in accrued expenses. Stockholders' equity increased to $497,068 from $99,967 at the end of the prior quarter.
The company reported 13.54 million common shares outstanding as of January 31, 2026, compared to 11.59 million at October 31, 2025. Loss per share was $0.05 compared to $0.43 in the year-earlier quarter.
Kaival Brands faces regulatory challenges including marketing denial orders from the FDA for both tobacco-flavored and non-tobacco flavored BIDI Stick products, as well as an ongoing patent infringement investigation by the International Trade Commission.
Financial Summary
| Period Ending January 31 | 2026 | 2025 |
|---|---|---|
| Total Revenue | $92,938 | $202,603 |
| Operating Expenses | $713,725 | $4,278,533 |
| Net Loss | ($620,787) | ($4,061,080) |
| Loss Per Share | ($0.05) | ($0.43) |
| Cash | $797,500 | $2,427,612 |